Found: 6
Select item for more details and to access through your institution.
Lysosomal Ca<sup>2+</sup>-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28874-9
- By:
- Publication type:
- Article
Pancreatic β-cell mitophagy as an adaptive response to metabolic stress and the underlying mechanism that involves lysosomal Ca<sup>2+</sup> release.
- Published in:
- Experimental & Molecular Medicine EMM, 2023, v. 55, n. 9, p. 1922, doi. 10.1038/s12276-023-01055-4
- By:
- Publication type:
- Article
A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1307739
- By:
- Publication type:
- Article
A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03939-w
- By:
- Publication type:
- Article
An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20454-z
- By:
- Publication type:
- Article
Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187515
- By:
- Publication type:
- Article